Foundation Healthcare IPO: A S$1B Giant With Zero Dividends | EP1670 🦖
Everyone is staring at the Temasek-backed label and the billion dollar headline, but what caught my attention is what income investors are not getting for the next two years. A private medical roll-up can look like a safe healthcare play on the surface, until you look at the structure underneath. The whole model depends on continuous acquisitions and consultants staying put, not on a steady cash payout.
If a new S$1.0 to S$1.2 billion healthcare IPO is guiding for zero dividends in 2026 and 2027, while a mature peer like Raffles Medical is still paying out around 3 percent, the question for CPF and SRS investors is straightforward: what are you being paid for taking on that extra execution and concentration risk? In this episode I walk through how the roll-up model, the heavy cornerstone allocation, and the zero-yield guidance change the picture for income-focused portfolios. Worth watching before you decide whether this belongs next to your T-bills or stays on the watchlist. Iggy has the forensic read on where this sits against the zone framework in a separate post.
📩 Substack: https://investingiguana.com/p/foundation-healthcare-ipo-a-s1b-giant
📺 YouTube: https://youtu.be/-eWzP126SiA
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
